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Multidrug drug resistant bacteria are becoming increasingly problematic particularly in
the under developed countries of the world. The most important microorganisms that
have seen a geometric rise in numbers are Methicillin resistant Staphylococcus aureus,
Vancomycin resistant Enterococcus faecium, Penicillin resistant Streptococcus pneumonia
and multiple drug resistant tubercule bacteria to name a just few. New drug scaffolds
are essential to tackle this every increasing problem. These scaffolds can be sourced
from nature itself. Endophytic fungi are an important reservoir of therapeutically active
compounds. This review attempts to present some data relevant to the problem.
New, very specific and effective antibiotics are needed but also at an affordable price!
A Herculean task for researchers all over the world! In the Asian subcontinent indigenous
therapeutics that has been practiced over the centuries such as Ayurveda have been
effective as “handed down data” in family generations. May need a second, third and
more “in-depth investigations?”
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INTRODUCTION
The last two decades have witnessed a rise in the numbers of
Methicillin resistant Staphylococcus aureus (MRSA), Vancomycin
resistant Enterococcus faecium (VRE) and Penicillin resistant
Streptococcus pneumoniae (PRSP) and a variety of antibiotics
(Menichetti, 2005). New drugs such as Linezolid and Daptomycin
have already acquired resistance (Mutnick et al., 2003; Skiest,
2006). MDR- and XDR-TB (Gillespie, 2002; LoBue, 2009) are
emerging global threats, being difficult to diagnose, expensive
to treat and with variable results. Rice (2008) reported that the
ESKAPE organism’s E. faecium, S. aureus, Klebsiella pneumoniae,
Acinetobacter baumanii, P. aeruginosa, and Enterobacter species
are the main causative agents of infections in a majority of US
hospitals. To combat all these continuing developments, a search
for new and novel drugs scaffolds remains the high priority
activity.
Eighty five years after the discovery of Penicillin in 1929, sci-
entists all over the world continue to investigate natural products.
The novelty of structures and scaffolds, their varied bioactivities
plus their abilities to act as lead molecules is immense. According
to Newman and Cragg (2012), in the years 1981–2010, ∼50%
of all small molecules originated from natural products. Mainly
antibacterial, anticancer, antiviral and antifungals compounds
from natural sources such as plant, fungi and bacteria themselves.
The extraordinary advantages of natural products as sources of
biotherapeutics is beyond question.
Though diverse chemical compounds with equally diverse
scaffolds and bioactivities have been reported from fungi over
the years, the vast group still remains to be fully exploited.
Out of ∼1 million different fungal species only ∼100,000 have
been described (Hawksworth and Rossman, 1997). Dreyfuss and
Chapela (1994) estimated that endophytic fungi, alone could
be ∼1 million. The genetic diversity of fungal endophytes may
be a major factor in the discovery of novel bioactive compounds
(Gunatilaka, 2006). The true potential of these endophytes is yet
to be trapped.
From the first reports of isolation from the Lolium temulen-
tum typically known as Darnel (ryegrass) by Freeman (1904), to
the latest one from Antarctic moss (Melo et al., 2014), endophytic
fungi have attracted the attention of botanists, chemists, ecolo-
gists, mycologists, plant pathologists and pharmacologists. It is
estimated that each and every of the almost 300,000 plants that
exist, hosts one or more endophyte (Strobel and Daisy, 2003).
They occur everywhere, from the Arctic to Antarctic and temper-
ate to the tropical climates. Endophytes reside in internal tissues
of living plants but this association does not cause any immedi-
ate, overt, negative effects on the host plant (Bacon and White,
2000). According to Aly et al. (2011), the endophyte-plant host
relationship is a balanced symbiotic continuum, ranging from
mutualism through commensalism to parasitism. Many endo-
phytic fungi remain quiescent within their hosts until it stressed
or begins to undergo senescence. At this juncture the fungi may
turn pathogenic (Rodriguez and Redman, 2008).
The impact of endophytes on our lives is seen in several of
ways; from an insecticidal bio fumigant from theMuscodor albus,
against adults and larvae of potato tubermoths (Lacey andNeven,
2006) to synthesis of “myco-diesel” by Gliocladium roseum, in the
hope of alternate fuel options (Strobel et al., 2008). Between these
extremes, endophytes has been shown to produce several pharma-
cologically important compounds such as antimycotics Cryptocin
(Li et al., 2000) and Ambuic acid (Li et al., 2001), anticancer
Torreyanic acid (Lee et al., 1996), Taxol (Strobel et al., 1996), anti-
inflammatory Ergoflavin (Deshmukh et al., 2009), antidiabetic
(nonpeptidal compound L-783,281) (Zhang et al., 1999), antiox-
idant Pestacin (Harper et al., 2003), Isopestacin (Strobel et al.,
2002), antiviral Cytonic acids A and B (Guo et al., 2000), alkaloids
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and polyketides Sclerotinin A (Lai et al., 2013), Cryptosporioptide
(Saleem et al., 2013), enzyme inhibitors- Fusaric acid deriva-
tives (Chen et al., 2013), Anthraquinones (Hawas et al., 2012)
and immunosuppressive agents Subglutinols A and B (Lee et al.,
1995).
The need for novel antibacterials to combat this increasing
variety of infections becomes a priority endeavor. Endophytic
fungi may be an important source for such biotherapeutics like
new antibacterials against Mycobacterium tuberculosis especially
in poverty ridden tropical countries of Asia. Here the need could
also involve a nutritional efforts to boost the immunity in the
population. Many of the compounds with their host plants are
shown in Table 1.
ANTIBACTERIALS FROM ENDOPHYTIC FUNGI
COMPOUNDS FROM ASCOMYCETES
Ascomycetes are an important class of fungi where there is forma-
tion of ascospores. Some genera of this class are prolific producer
of bioactive metabolites. The genus Pestalotiopsis exists as an
endophyte in most of the world’s rainforests and is extremely bio-
chemically diverse. Some examples of products from this group
are Ambuic acid (1) and its derivative (2) (Figure 1) isolated from
a Pestalotiopsis sp. of the lichen Clavaroid sp. Compounds (1) and
(2) are active against S. aureus (ATCC 6538) with IC50 values of
43.9 and 27.8μM, respectively (the positive control Ampicillin
showed an IC50 value of 1.40μM) (Ding et al., 2009).
Pestalotiopen A (3) (Figure 1), from Pestalotiopsis sp. of the
Chinese mangrove Rhizophora mucronata exhibited moderate
antimicrobial activity against Enterococcus faecalis with an MIC
value between 125 and 250μg/mL (Hemberger et al., 2013).
A novel phenolic compound, 4-(2, 4, 7-trioxa-bicyclo
[4.1.0] heptan-3-yl) phenol (4) (Figure 1) was isolated from
Pestalotiopsis mangiferae associated with Mangifera indica. The
compound exhibits activity against Bacillus subtilis and K. pneu-
moniae (MICs 0.039μg/ml), E. coli and Micrococcus luteus
(MICs 1.25μg/ml) and P. aeruginosa (MIC 5.0μg/ml). The pos-
itive control (Gentamycin) is showed activity against B. sub-
tilis, K. pneumoniae and M. luteus, E. coli, and P. aeruginosa
(MICs range 5.0–10.0μg/ml). Transmission electron microscopy
(TEM) analysis for mode of action of compound (4) showed
that against the three human pathogens (E. coli, P. aerug-
inosa, and K. pneumoniae), morphological alterations took
place: such as destruction of bacterial cells by cytoplasmic
agglutination and formation of pores in cell wall membranes
(Subban et al., 2013).
Pestalone (5) (Figure 1) is a chlorinated benzophenone antibi-
otic produced by a co-cultured Pestalotia sp./Unicellular marine
bacterium strain CNJ-328. Pestalotia sp. was isolated from the
brown alga Rosenvingea sp. collected in the Bahamas Islands.
Pestalone exhibits potent activity against MRSA (MIC 37 ng/mL)
and VRE (MIC 78 ng/mL), indicating that Pestalone should be
evaluated in advanced models of infectious disease (Cueto et al.,
2001). It is active against S. aureus strain SG511, MRSA LT-1334
and Bacillus subtilis 168 with MICs of 3.1, 6.25, and 1.6μg/mL
respectively (Augner et al., 2013).
Phomopsis, another important genus exists as an endophyte in
most plants and is also extremely biochemically diverse. Examples
of bioactive metabolites from this endophyte are Dicerandrol A
(6), B (7), and C (8) (Figure 1) from Phomopsis longicolla of the
mintDicerandra frutescens. They exhibit zones of inhibition of 11,
9.5, and 8.0mm against B. subtilis respectively and 10.8, 9.5, and
7.0mm respectively against S. aureus when tested at 300μg/disc
(Wagenaar and Clardy, 2001).
Dicerandrol C (8) (Figure 1) was isolated from Phomopsis
longicolla strain C81, from the red seaweed Bostrychia radicans.
Dicerandrol C (8) had significant antimicrobial activity against
S. aureus (ATCC 6538) and Staphylococcus saprophyticus (ATCC
15305), with MICs of 1 and 2μg /mL respectively (Erbert et al.,
2012).
Dicerandrol A (6), Dicerandrol B (7), Dicerandrol C (8),
Deacetylphomoxanthone B (9) and Fusaristatin A (10) (Figure 1)
were isolated from Phomopsis longicolla S1B4 from a plant sam-
ple from Hadong-gun, Kyungnam Province, South Korea. All of
the above compounds show moderate to low antibacterial activ-
ities against Xanthomonas oryzae KACC 10331 with MICs of 8,
16, >16, 4, and 128μg/mL respectively. Dicerandrol A (6) is
also active against S. aureus KCTC 1916, B. subtilis KCTC 1021,
Clavibacter michiganesis KACC 20122, Erwinia amylovora KACC
10060, with MICs value of 0.25, 0.125, 1.0, and 32.0μg/mL
respectively (Lim et al., 2010). Monodeacetylphomoxanthone B
(11) (Figure 1) was reported from the same culture along with
compounds (6–9). It is active against X. oryzae with an MIC of
32μg/mL (Choi et al., 2013).
Phomoxanthones A (12) and B (13) (Figure 1) were obtained
from Phomopsis sp. BCC 1323, of the leaf of Tectona grandis
L., from the Mee Rim district of Chaingmai Province, Northern
Thailand. These compounds show significant “in vitro” antitu-
bercular activities with MICs of 0.5 and 6.25μg/mL respectively
against Mycobacterium tuberculosis H37Ra strain, in compari-
son to isoniazide and kanamycin sulfate (MICs of 0.050 and
2.5μg/mL, respectively) that are used in clinics today (Isaka et al.,
2001).
Phomoxanthone A (12) (Figure 1), was also isolated from a
Phomopsis sp. of the stem of Costus sp. growing in the rain forest
of Costa Rica. It has activity against Bacillus megaterium at a con-
centration of 10mg/mL (radius of zone of inhibition of 3–4 cm)
(Elsaesser et al., 2005).
Cycloepoxylactone (14) (Figure 1) and cycloepoxytriol B (15)
(Figure 2) were detected from Phomopsis sp. (internal strain
no. 7233) of Laurus azorica. They are moderately active against
B. megaterium (Hussain et al., 2009a).
Phomosines A–C (16–18) (Figure 2), three new biaryl ethers
were obtained from Phomopsis sp. of the leaves of Teucrium
scorodonia. All three compounds were moderately active against
B. megaterium and E. coli in vitro, using 6mm filter paper disc
with 50μl each of a 15mg/mL solution (Krohn et al., 1995). The
same compounds were obtained from Phomosis sp. of Ligustrum
vulgare and showed activity against B. megaterium in vitro with
10, 10, and 7mm zone of inhibition using 6mm filter paper disc
and 50μg of compound (50μL of 1mg/mL) respectively (Krohn
et al., 2011).
Phomosine A (16) and Phomosine G (19) (Figure 2) were iso-
lated from Phomopsis sp. of the halo tolerant plant Adenocarpus
foliolosus from Gomera. Both the compound exhibited moderate
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antibacterial activities against B. megaterium (Dai et al.,
2005).
Phomosine K (20), 2-hydroxymethyl-4β,5α, 6β-trihydroxy-
cyclohex-2-en (21), (−)-Phyllostine (22), (+)-Epiepoxydon (23),
and (+)-Epoxydon monoacetate (24) (Figure 2) were iso-
lated from a Phomopsis sp. of Notobasis syriaca. Phomosine
K (20) is active against Legionella pneumophila Corby, E. coli
K12 and B. megaterium in vitro while 2-hydroxymethyl-
4β,5α,6β-trihydroxycyclohex-2-en (21), (−)-Phyllostine (22),
(+)-Epiepoxydon (23), and (+)-Epoxydon monoacetate (24)
showed moderate activities against E. coli K12 and B. megaterium
(Hussain et al., 2011).
Phomopsinone B (25) and C (26) from a Phomopsis sp. present
in stems of Santolina chamaecyparissus from Sardinia showed
moderate activities against E.coli, and B. megaterium (Hussain
et al., 2012b).
Phomochromone A (27), B (28), Phomotenone (29), and
(1S, 2S, 4S)-trihydroxy-p-menthane (30) (Figure 2) were isolated
from a Phomopsis sp. ofCistus monspeliensis. All three compounds
(27–30) show activity against E. coli and B. megaterium (Ahmed
et al., 2011).
Pyrenocines J-M (31–34) (Figure 2) were isolated from a
Phomopsis sp. of the plant Cistus salvifolius, internal strain 7852.
All four compounds (31–34) are active against B. megaterium and
E. coli (Hussain et al., 2012a).
3-Nitropropionic acid (35) (Figure 2) was isolated from sev-
eral strains of endophytic fungus of the genus Phomopsis sp.
obtained from six species of Thai medicinal plants (Table 1) from
the forest areas of Chiangmai, Nakhonrachasima, and Pitsanulok
Provinces of Thailand. 3-Nitropropionic acid exhibits potent
activity against Mycobacterium tuberculosis H37Ra with the MIC
of 3.3μM, but no in vitro cytotoxicity was observed toward a
number of cell lines (Chomcheon et al., 2005). 3-Nitropropionic
acid is known to inhibit isocitrate lyase (ICL), an enzyme required
for fatty acid catabolism and virulence inM. tuberculosis (Muñoz-
Elías and McKinney, 2005).
Phoma is another genus which produces diverse compounds.
Here are some examples of bioactive compounds produced by this
genus. Phomol (36) (Figure 3), a novel antibiotic, was isolated
from a Phomopsis sp. of the medicinal plant Erythrina crista-galli.
Phomol is active against Arthrobacter citreus andCorynebacterium
insidiosum with MICs of 20 and 10μg/mL respectively (Weber
et al., 2004).
Phomodione (37), an usnic acid derivative was isolated from a
Phoma sp. of Saurauia scaberrinae. Phomodione was found to be
effective against S. aureus at a MIC of 1.6μg/mL (Hoffman et al.,
2008).
The antibacterials Epoxydine B (38), Epoxydon (39), (4R,
5R,6S)-6-acetoxy-4,5-dihydroxy-2-(hydroxymethyl)cyclohex-2-
en-1-one (40), 2-chloro-6-(hydroxymethyl)benzene-1,4-diol
(41), and the antibiotic ES-242-1 (42) (Figure 3), were isolated
from a Phoma sp. of Salsola oppostifolia. Compounds (38–42)
show activity against E. coli and B. megaterium (Qin et al.,
2010).
Antibacterials (+)-Flavipucine (43) and (−)-Flavipucine (44)
(Figure 3), were isolated from a Phoma sp., of the plant Salsola
oppositifolia. (+)-Flavipucine (43) is active against B. subtilis,
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FIGURE 1 | Structures of antibacterial metabolites isolated from Ascomycetes (1–14).
S. aureus, E. coli with inhibition zones of 16, 17, and
11mm, respectively in disc diffusion assay at 15μg/6mm. (−)-
Flavipucine (44) was active against B. subtilis and E. coli at MIC of
25μg/ mL (Loesgen et al., 2011).
Three new alkaloids, Phomapyrrolidones B-C (45–46)
(Figure 3), were isolated from a Phoma sp. NRRL 46751, of the
plant Saurauia scaberrinae. Phomapyrrolidones B (45) and C (46)
show weak in vitro activities when tested in microplate Alamar
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FIGURE 2 | Structures of antibacterial metabolites isolated from Ascomycetes (15–35).
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FIGURE 3 | Structures of antibacterial metabolites isolated from Ascomycetes (36–47).
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Blue assays (MABA) with MICs of 5.9 and 5.2μg/mL respectively
and in the low oxygen recovery assay (LORA) with MICs of 15.4
and 13.4μg/mL respectively, for nonreplicating M. tuberculosis
H37Pv (Wijeratne et al., 2013).
Other endophytes of Ascomycetes are also known to produce
antibacterials. For example Colletotric acid (47) (Figure 4) from
Colletotrichum gloeosporioides of Artemisia mongolica or Nanjing,
China inhibits B. subtilis, S. aureus, and Sarcina lutea with MICs





ergosta-7,22-dien-3β,5α,6β-triol (52), and (22E,24R)-3,6-
diacetoxy-ergosta-7,22-dien-3β,5α,6β-triol (53) (Figure 4),
were isolated from a Colletotrichum sp. of Ilex canariensis
from Gomera. Compounds (48–53) are active against E. coli
and B. megaterium of 0.05μg/ filter paper disc of 6mm
FIGURE 4 | Structures of antibacterial metabolites isolated from Ascomycetes (48–64).
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diameter (Zhang et al., 2009). Antibacterial 1-hydroxy-5-metho-
xynaphthalene (54), 1,5-dimethoxy-4-nitronaphthalene (55),
1-hydroxy-5-methoxy-2,4-dinitronaphthalene (56) (Figure 4),
were isolated from Coniothyrium sp. internal strain number
7721 of the shrub Sideritis chamaedryfolia, from an arid zone
near Alicante, Spain. These compounds were active against
B. megaterium and E. coli (Krohn et al., 2008a).
(−)-Trypethelone (57), isolated from endophyte
Coniothyrium cereale of the marine green alga Enteromorpha
sp. showed activity against Mycobacterium phlei, S. aureus, and
E. coli, at 20μg/disk with inhibition zones of 18, 14, and 12mm,
respectively (Elsebai et al., 2011).
Antibacterials Pachybasin (58), 1, 7-Dihydroxy-3-methyl-9,
10-anthraquinone (59), Phomarin (60), 1-Hydroxy-3-
hydroxymethyl-9, 10-Anthraquinone (61), and Coniothyrinones
A-D (62–65) (Figures 4, 5), were isolated from Coniothyrium
sp., an endophyte of Salsola oppostifolia from Gomera in the
Canary Islands. Compounds (58–65) were active against E. coli
and B. megaterium in vitro in disc diffusion assay at 50μg/9mm
disc dissolved in acetone (Sun et al., 2013a).
3-Hydroxypropionic acid (3-HPA) (66) (Figure 5) was iso-
lated from the mangrove endophyteDiaporthe phaseolorum, from
branches of Laguncularia racemosa, growing in Bertioga, located
in south eastern Brazil. 3-HPA was active against both S. aureus
and Salmonella typhi at an MIC of 64μg/mL (Sebastianes et al.,
2012).
Botryomaman (67), 2, 4-Dimethoxy-6-pentylphenol (68),
(R)—(−)-Mellein (69), Primin (70), cis-4-hydroxymellein (71),
trans-4-hydroxymellein (72) and 4, 5-dihydroxy-2-hexenoic acid
(73) (Figure 5) were isolated from the endophyte Botryosphaeria
mamane PSU-M76 from the leaves of Garcinia mangostana, col-
lected in Suratthani Province, Thailand. The compounds were
active against S. aureus ATCC 25923 and MRSA SK1. Primin was
the most active with MIC values of 8μg/mL against both the
strains (Pongcharoen et al., 2007).
Microdiplodia sp. isolated from the shrub Lycium intricatum
gave Diversonol (74), Microdiplodiasol (75), Microdiplodiasone
(76), Microdiplodiasolol (77), (−)-Gynuraone (78), and
Ergosterol (79) (Figure 5). Compounds (74–79) were active
against Legionella pneumophila (Siddiqui et al., 2011).
Polyketide metabolites, 7,8-dihydonivefuranone A (80), 6(7)-
dehydro-8-hydroxyterrefuranone (81), 6-hydroxyterrefuranone
(82) and Nivefuranones A (83) (Figure 6) were isolated from a
Microdiplodia sp. KS 75-1 from the stems of conifer trees (Pinus
sp.). Compounds (80–83) were active against S. aureus NBRC
13276 with zone of inhibition of 15, 15, 16, and 15mm respec-
tively, tested at 40μg/per disc of 8mm diameter (Shiono et al.,
2012).
1β-hydroxy-α-cyperone (84) (Figure 6) was isolated from
the endophyte Microsphaeropsis arundinis found in stems of
Ulmus macrocarpa collected from Dongling Mountain, Beijing,
People’s Republic of China. Compound (84) inhibits S. aureus
(CGMCC1.2465), at an MIC of 11.4μg/mL. Ampicillin (positive
control) showed an MIC value of 0.46μg/mL (Luo et al., 2013).
Microsphaeropsone A (85) and Microsphaeropsone C (86)
(Figure 5), were isolated from Microsphaeropsis sp. (strain 8875)
from the plant Lycium intricatum, co-occurs with their putative
biogenetic Anthraquinoide precursors and Citreorosein (87).
From a Microsphaeropsis species (strain no. 7177) of the plant
Zygophyllum fortanesii from Gomera (Spain), large amounts of
Fusidienol A (88) and the known aromatic xanthones (89), were
isolated. The endophyte Seimatosporium species (internal strain
no. 8883) of Salsola oppositifolia from Gomera (Spain), produced
3, 4-dihydroglobosuxanthone A (90). Compounds (85–90) were
active against E. coli and B. megaterium (Krohn et al., 2009).
Dinemasones A(91) and B (92) (Figure 5), were isolated from
Dinemasporium strigosum obtained from the roots of the herba-
ceous plant Calystegia sepium growing on the shores of the Baltic
Sea, Wustrow, Germany. The above compounds showed antibac-
terial activities against B. megaterium (Krohn et al., 2008b).
Cytosporone D (93) and E (94) (Figure 7), were isolated from
the endophyte CR200 (Cytospora sp.) and CR146 (Diaporthe sp.)
present in tissues of Conocarpus erecta and Forsteronia spicata
plants respectively collected in the Guanacaste Conservation Area
of Costa Rica. Cytosporone D (93) shows antibacterial activ-
ity against S. aureus, E. faecalis, and E. coli with MICs of 8, 8,
and 64μg/mL respectively, while Cytosporones E (94) has similar
activity against S. aureus (Brady et al., 2000).
Cytosporone D (93), E (94), and Cytoskyrin A (95) (Figure 7),
were isolated from a Cytospora sp. CR200 from a branch of
Conocarpus erecta (Buttonwood tree) in the Guanacaste National
Park, from Costa Rica. Cytoskyrin A (95) has good in-vitro
antibacterial activity (MICs against (S. aureus ATCC 29923,
S. aureus ATCC6538P, S. aureus #310 (MRSA), E. faecium #379
(VREF), E. faecium # 436 (VSEF), B. subtilis BGGS1A1, E. coli
imp BAS849), ranging from 0.03 to 0.25μg/mL). Cytosporone
D (93) and E (94) have moderate in-vitro antibacterial activ-
ity against above mentioned bacteria (MICs 8–64μg/mL) (Singh
et al., 2007).
Two new benzyl γ-butyrolactone analogs, (R)-5-((S)-
hydroxy(phenyl)-methyl)dihydrofuran-2(3H)-one (96) and its
6-acetate (97), a new naphthalenone derivative (98), together
with aromatic derivatives, (S)-5-((S)-hydroxy(phenyl)-methyl)
dihydrofuran-2(3H)-one (99), (S)-5-benzyl-dihydrofuran-
2(3H)-one (100), 5-phenyl-4-oxopentanoic acid (101),
gamma-oxo-benzenepentanoic acid methyl ester (102), 3-
(2,5-dihydro-4-hydroxy-5-oxo-3-phenyl-2-furyl)propionic acid
(103), (3R)-5-methylmellein (104), Integracins A (105), and
B (106) (Figure 7) were isolated from Cytospora sp., of Ilex
canariensis from Gomera. Compounds (96- 106) are active
against B. megaterium, zone size range 15–25mm when 50μL
of a solution (0.05mg/mL substance) are pipetted onto 9mm a
sterile filter paper disc (Lu et al., 2011).
Chaetoglobosin B (107) (Figure 8), isolated from the endo-
phyte Chaetomium globosum from the leaves of Viguiera robusta
showed weak antibacterial activity against S. aureus (MIC
120μg/mL) and E. coli (MIC 189μg/mL) (Momesso et al., 2008).
Chaetoglocins A-B (108–109) (Figure 8) isolated from
Chaetomium globosum strain IFB-E036, an endophyte from
Cynodon doctylon have antimicrobial activity against B. subtilis,
Streptococcus pyogens, Micrococcus luteus and Mycobacterium
smegmatis with MICs between 8 and 32μg/mL (Ge et al., 2011).
Antibacterial compounds Acremonisol A (110),
Semicochliodinol A (111), Cochliodinol (112), were isolated
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FIGURE 5 | Structures of antibacterial metabolites isolated from Ascomycetes (65–79).
from C. globosum SNB-GTC2114 and Pyrrocidine A (113),
B (114), C (115), and Alterperylenol (116) (Figure 8) were
isolated from Lewia infectoria SNB-GTC2402 obtained from
Besleria insolita from the Amazon Rainforest biome of Cayenne
and Roura, French Guiana. Compounds (110–112, 115,
and 116), exhibited antibacterial activity against S. aureus
ATCC 29213 with MICs of 64, 2, 4, 2, and 32μg/mL respec-
tively. Compounds (113–114) were active against S. aureus
ATCC 29213, with a MIC value of 5μg/mL (Casella et al.,
2013).
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FIGURE 6 | Structures of antibacterial metabolites isolated from Ascomycetes (80–92).
7-amino-4-methylcoumarin (117) (Figure 8) was isolated
from the endophyte Xylaria sp., of Ginkgo biloba. The com-
pound showed strong antibacterial against S. aureus, E. coli, S.
typhi, Salmonella typhimurium, Salmonella enteritidis, Aeromonas
hydrophila, Yersinia sp., Vibrio anguillarum, Shigella sp., and
Vibrio parahaemolyticus with MIC of 16, 10, 20, 15, 8.5,
4, 12.5, 25, 6.3, and 12.5μg/mL respectively (Liu et al.,
2008).
1-(xylarenone A)xylariate A (118), Xylarioic acid B (119)
(Figure 8), Xylariolide A (120), Xylariolide B (121), Xylariolide
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FIGURE 7 | Structures of antibacterial metabolites isolated from Ascomycetes (93–106).
C (122), Me-xylariate C (123), Xylariolide D (124), and tai-
wapyrone (125) (Figure 9), were isolated from Xylaria sp. NCY2
of Torreya jackii Chun collected from Jiangshi Nature Reserve
Zone of Fujian Province, China. Compounds (118–125) are
active against E. coli ATCC 25922, B. subtilis ATCC 9372 and
S. aureus ATCC 25923 with MIC values above 10μg/mL (Hu
et al., 2010).
The polyketide, Cryptosporioptide (126) (Figure 9) was iso-
lated from a Cryptosporiopsis sp., from the shoot tissues of the
shrub Viburnum tinus, collected from Gomera. At 50μg per
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FIGURE 8 | Structures of antibacterial metabolites isolated from Ascomycetes (107–119).
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FIGURE 9 | Structures of antibacterial metabolites isolated from Ascomycetes (120–139).
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9mm paper disc, it inhibits B. megaterium, showing a 9mm
radius of zone of inhibition (Saleem et al., 2013).
Monocerin (127), (12S)-12-hydroxymonocerin (128) and
Isocoumarin (129) (Figure 9) were isolated from Microdochium
bolleyi, an endophyte from Fagonia cretica. All these compounds
were active against E. coli and B. megaterium (Zhang et al., 2008a).
Isofusidienol A (130), B (131), C (132), and D (133) (Figure 9)
were isolated from a Chalara sp. strain 6661, an endophyte
of Artemisia vulgaris, collected from Ahrenshoop, Germany
Compounds (130) and (131) showed strong antibacterial activ-
ities against B. subtilis with inhibition zones of 23 and 22mm
respectively, at 15μg of compounds per 6-mm filter disks. Under
the same conditions, 15μg of Penicillin G has a zone of 50-mm
diameter. The MIC of compound (130) was shown to be 0.625μg
on 6-mm filter disks. Compound (130) shows moderate activity
against S. aureus and E. coli with an inhibition zone diameter of
9 and 8mm, respectively, at 15μg of compound per 6-mm filter
disk. Compound (132) and (133) show inhibition zone of 9 and
8mm against B. subtilis at 15μg per 6-mm filter disk (Loesgen
et al., 2008).
Secalonic acid B (134), Blennolides A (135) and B (136)
(Figure 9) were isolated from a Blennoria sp., an endophyte of
Carpobrotus edulis, from El Cedro, Gomera. Compounds (134–
136) inhibit B. megaterium, and compounds (135) and (136) also
inhibited E. coli (Zhang et al., 2008b).
Spiropreussione A (137) (Figure 9) was obtained from an
endophyte, Preussia sp., of the mature stems of Aquilaria sinen-
sis (Thymelaeaceae), collected from the Guangxi Medicinal
Arboretum. Spiropreussione A (137) shows activity against
S. aureus (CMCC B26003) with a zone of inhibition of 16.4 ±
0.3mm (n = 3) at 5μg/disk. The MIC of the compound in agar
dilution test using NCCLS 2002 guide lines was 25μM (Chen
et al., 2009).
Monomethylsulochrin (138), Rhizoctonic acid (139),
(Figure 9) and Guignasulfide (140) (Figure 10) were isolated
from a Guignardia sp. IFB-E028, an endophyte of Hopea haina-
nensis and show moderate activity against the human bacterial
pathogen Helicobacter pylori with MIC values of 28.9, 60.2, and
42.9μM, respectively (Wang et al., 2010).
Helvolic acid (141) (Figure 10) was isolated from the endo-
phyte Pichia guilliermondii Ppf9 of medicinal plant Paris poly-
phylla var. yunnanensis. Compound (141) has strongest antibac-
terial activity on Agrobacterium tumefaciens, E. coli, Pseudomonas
lachrymans, Ralstonia solanacearum, Xanthomonas vesicatoria,
B. subtilis, S. aureus, and Staphylococcus haemolyticus, with MICs
of 1.56, 3.13, 3.13, 1.56, 1.56, 3.13, 50, and 6.25μg/mL, respec-
tively (Zhao et al., 2010).
Chlorogenic acid (142) (Figure 10) was isolated from the
endophyte strain B5 a Sordariomycete sp. of Eucommia ulmoides.
Eucommia ulmoides is a medicinal plant of China and one of the
main sources of Chlorogenic acid. It has antibacterial, antifungal,
antioxidant and antitumor activities (Chen et al., 2010).
Antibacterial Biscogniazaphilones A (143) and B (144),
N-trans-feruloy-3-O-methyldopamine (145), 5-Hydroxy-3,7,4-
trimethoxyflavone (146), 4-Methoxycinnamaldehyde (147),
Methyl 3,4-methylenedioxycinnamate (148), 4-Methoxy-
trans-cinnamic acid (149), (Figure 10) were isolated from
the endophyte Biscogniauxia formosana BCRC 33718, of
Cinnamomum sp. Compounds (143) and (144) show antimy-
cobacterial activities against M. tuberculosis strain H37Rv
in vitro showing MIC values of ≤5.12 and ≤2.52μg/mL, respec-
tively, than the clinical drug Ethambutol (MIC 6.25μg/mL).
Compounds (145–149) show moderate to weak antimycobacte-
rial activities with MICs of 12.5, 25.0, 42.1, 58.2, and 50.0μg/mL,
respectively (Cheng et al., 2012).
Dothideomycetide A (150) (Figure 10) from an endophyte a
Dothideomycete sp., of a Thai medicinal plant, Tiliacora triandra,
has antibacterial activity against S. aureusATCC 25923 andMRSA
ATCC 33591 with MIC values of 128 and 256μg/ mL respectively
(Senadeera et al., 2012).
Cristatumins A (151) and Tardioxopiperazine A (152)
(Figure 10) were produced by the endophyte Eurotium cristatum
EN-220 of marine alga Sargassum thunbergii and showed activity
against E. coli and S. aureus with MIC values of 64 and 8μg/mL,
respectively (Du et al., 2012).
COMPOUNDS PRODUCED BY HYPHOMYCETES
Hyphomycete form a class of fungi which produces the asex-
ual spores. Producers of the antibacterials Penicillins and
Cephalosporins belong to this class. Other antibacterials from this
class are Helvolic acid (141) (Figure 10), Monomethylsulochrin
(138) (Figure 9), Ergosterol (79) (Figure 5) and 3β-Hydroxy-5α,
8α-epidioxy-ergosta-6, 22-diene (153) (Figure 11) were isolated
from an endophyte Aspergillus sp. CY725 of Cynodon dactylon
(Poaceae). Compounds (141), (138), (79), and (153) are active
against H. pylori with MICs of 8.0, 10.0, 20.0, and 30.0μg/mL
respectively. Helvolic acid (141) is active against Sarcina lutea and
S. aureus with MICs of 15.0 and 20.0μg/mL respectively (Li et al.,
2005).
Aspergicin (154) and Neoaspergillic acid (155) (Figure 11)
were isolated from a mixture of cultured mycelia of two marine-
derived mangrove epiphytic Aspergilli FSY-01 and FSW-02.
Aspergicin (154) has anti-bacterial activity against S. aureus,
S. epidermidis, B. subtilis, B. dysenteriae, B. proteus, and E. coli,
with MICs of 62.5, 31.25 15.62, 15.62 62.5, and 31.25μg/mL
respectively. Neoaspergillic acid (155) has antibacterial activity
against S. aureus, S. epidermidis, B. subtilis, B. dysenteriae, B. pro-
teus, and E. coli, with MICs of 0.98, 0.49, 1.95, 7.8, 7.8, and
15.62μg/mL respectively (Zhu et al., 2011).
Two new dihydroisocoumarin derivatives Aspergillumarins A
(156) and B (157) (Figure 11) are produced by a marine-derived
Aspergillus sp., of the mangrove Bruguiera gymnorrhiza collected
from the South China Sea. Both show weak antibacterial activ-
ities against S. aureus and B. subtilis at 50μg/mL (Li et al.,
2012).
Brevianamide M (158), 6, 8-di-O-methylaverufin (159)
and 6-O-Methylaverufin (160) (Figure 11), were isolated from
Aspergillus versicolor a fungus of themarine brown alga Sargassum
thunbergii. These compounds have activities against S. aureus and
E. coli (Miao et al., 2012).
Isorhodoptilometrin-1-Me ether (161), Siderin (162)
(Figure 11), were isolated from the marine fungus Aspergillus
versicolor of inner tissues of the Red Sea green alga Halimeda
opuntia. Both the compounds show moderate activity against
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FIGURE 10 | Structures of antibacterial metabolites isolated from Ascomycetes (140–152).
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FIGURE 11 | Structures of antibacterial metabolites isolated from Hyphomycetes (153–165).
Bacillus cereus, B. subtilis, and S. aureus at a concentration of
50μg/disc of 9mm (Hawas et al., 2012).
Yicathin B (163) and C (164) (Figure 11) were isolated from
the endophyte Aspergillus wentii PT-1 of the red marine alga
Gymnogongrus flabelliformis. Tested in the agar diffusion assay at
10mg/disk compound (163) was active against E. coli (inhibition
zone diameter 9mm) and (164) a zone diameter of 12.0mm and
against S. aureus 7.5mm (Sun et al., 2013b).
The alkaloids, Fumigaclavine C (165) (Figure 11) and
Pseurotin A (166) (Figure 12) were isolated from the endophyte
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FIGURE 12 | Structures of antibacterial metabolites isolated from Hyphomycetes (166–177).
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Aspergillus sp. EJC08, of the medical plant Bauhinia guianen-
sis. Fumigaclavine C (165) has activity against B. subtilis, E. coli,
P. aeruginosa, and S. aureus with MICs of 7.81, 62.50, 31.25, and
15.62μg/mL respectively, while Pseurotin A (166) has activity
against B. subtilis, E. coli, P. aeruginosa, and S. aureuswithMICs of
15.62, 31.25, 31.25, and 15.62μg/mL respectively (Pinheiro et al.,
2013).
Pseurotin A (166) (Figure 12) was isolated from Penicillium
janczewskii of the Chilean gymnosperm Prumnopitys andina. The
compound showsmoderate activity against phytopathogenic bac-
teria Erwinia carotovora and Pseudomonas syringae, with IC50 val-
ues of 220 and 112μg/ mL, respectively (Schmeda-Hirschmann
et al., 2008).
(+)-Sclerotiorin (167) (Figure 12), was isolated from the
endophyte Penicillium sclerotiorum PSU-A13 (Arunpanichlert
et al., 2010). Compound (167) has been reported to have antibac-
terial activity against S. aureus ATCC 29213 (MIC 128μg/mL)
(Lucas et al., 2007).
Emodin (168) and Erythritol (169) (Figure 12) were isolated
from the endophyte Penicillium citrinum strain ZD6 of the stems
of Bruguiera gymnorrhiza. Emodin (168) and Erythritol (169)
inhibit the growth of B. subtilis with MIC values of 25μg/mL
and 50μg/mL respectively, while Emodin (168) was weakly active
against P. aeruginosa at an MIC value of 100μg/mL (Li et al.,
2010).
Antibacterial Conidiogenone B (170) and Conidiogenol (171)
(Figure 12) were isolated from Penicillium chrysogenum QEN-
24S, an endophyte of a marine red algal species of the genus
Laurencia. Conidiogenone B (170) has potent activity against
MRSA, Pseudomonas fluorescens, P. aeruginosa, and S. epidermidis
(at a concentration of 8μg/mL), while Conidiogenol (171) is
activity against P. fluorescens and S. epidermidis (both at an MIC
value of 16μg/mL) (Gao et al., 2011).
(3, 1′-didehydro-3[2′′ (3′′′, 3′′′-dimethyl-prop-2-enyl)-
3′′-indolylmethylene]-6-Mepipera-zine-2, 5-dione) (172)
(Figure 12) was isolated from Penicillium chrysogenum MTCC
5108, an endophyte of the mangrove plant Porteresia coarctata
(Roxb.), which has significant activity against Vibrio cholera
MCM B-322 (Devi et al., 2012).
Perinadine A (173), Alternariol (174), and Citrinin (175)
(Figure 12) were isolated from Penicillium citrinum present
on the flowers of Ocimum tenuiflorum (Lamiaceae) col-
lected in Denpasar, Bali, Indonesia. Compounds (173–175)
were moderately active against S. aureus ATCC 29213 (MICs
64μg/mL). These compounds, failed to inhibit the E. coli ATCC






methyl-4,8-sphingadienine (177) (Figure 12) were isolated from
a Fusarium sp. IFB-121, an endophyte of Quercus variabilis.
Both cerebrosides have strong antibacterial activities against
B. subtilis, E. coli and P. fluorescens with MIC values of 3.9, 3.9
and 1.9μg/mL and 7.8, 3.9, and 7.8μg/mL respectively (Shu
et al., 2004).
Fusapyridon A (178) (Figure 13) was isolated from Fusarium
sp. YG-45, an endophyte of the stem of Maackia chinensis, col-
lected at Gottingen (Germany). The compound is active against
P. aeruginosa and S. aureus, with MIC values of 6.25 and
50μg/mL, respectively (Tsuchinari et al., 2007).
Beauvericin (179) (Figure 13) was found in the endophyte
Fusarium redolens Dzf2, of the rhizomes of Dioscorea zingiberen-
sis. The IC50 values of Beauvericin against six test bacteria
viz. B. subtilis, Staphylococcus hemolyticus, Pseudomonas lachry-
mans, Agrobacterium tumefaciens, E. coli and X. vesicatoria were
between 18.4 and 70.7μg/mL (Xu et al., 2010b). Beauvercin
and (−)-4, 6′-anhydro-oxysporidinone (180) (Figure 13) were
isolated from the endophyte Fusarium oxysporum of the bark
of Cinnamomum kanehirae from Jiaoban Mountain, Taiwan
Province. Beauvericin (179) is active against MRSA and B. sub-
tilis at MICs of 3.125μg/mL. (−)-4, 6′-anhydro-oxysporidinone
(180) has weak anti-MRSA activity (MIC, 100μg/mL) and mod-
erate activity against B. subtilis (MIC, 25μg/mL) (Wang et al.,
2011).
Javanicin (181), 3-O-methylfusarubin (182), a diastereomer
of Dihydronaphthalenone (183) and 5-Hydroxy-3-
methoxydihydrofusarubin A (184) (Figure 13) were isolated from
the endophyte Fusarium sp. BCC14842 of Bamboo leaf, collected
from the Bamboo forest at Nam Nao National Park, Phetchabun
Province, Thailand. Compound (181), and (183) have moderate
activities (MICs of 25μg/mL) while 3-O-methylfusarubin
(182) and 5-hydroxy-3-methoxydihydrofusarubin A (184)
showed weak antimycobacterial activity (MICs of 50μg/mL)
(Kornsakulkarn et al., 2011).
Fusaric acid was obtained from a Fusarium sp. an endophyte of
a mangrove plant. Cadmium and Copper metal complexes were
prepared. The Cadmium (185) and Copper (186) (Figure 13)
complexes of fusaric acid exhibited potent inhibitory activity
against the Mycobacterium bovis BCG strain with MIC 4μg/mL
and theM. tuberculosisH37Rv strain with MIC 10μg/mL respec-
tively (Pan et al., 2011).
Fumitremorgin B (187), Fumitremorgin C (188), Helvolic
acid (141), Bisdethiobis (methylthio) gliotoxin (189) (Figure 13),
Bis-N-norgliovietin (190) and Gliotoxin (191) (Figure 14) were
isolated from the endophyte Fusarium solani of Ficus carica. All
compounds are active against B. subtilis, S. aureus, and E. coli and
P. aeruginosa with MICs in the range of 0.5–16μg/mL (Zhang
et al., 2012).
Lateropyrone (192), Enniatins B1 (193) and A1 (194)
(Figure 14), were isolated from mix culture fermentation of the
fungal endophyte Fusarium tricinctum and the bacterium B. sub-
tilis 168 trpC2 on solid rice medium. Fusarium tricinctum was
obtained from rhizomes of Aristolochia paucinervis of the moun-
tains of Beni-Mellal, Morocco. Enniatins B1 (193) and A1 (194),
inhibit the growth the B. subtilis strain (MICs of 16 and 8μg/mL,
respectively) and were also active against S. aureus, S. pneumo-
niae, and E. faecalis with MIC values in the range 2-8μg/mL.
Lateropyrone (192) has antibacterial activity against B. subtilis,
S. aureus, S. pneumoniae and E. faecalis, withMICs values ranging
from 2 to 8μg/mL. All the above compounds were equally effec-
tive against a multi-drug-resistant clinical isolate of S. aureus (Ola
et al., 2013).
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FIGURE 13 | Structures of antibacterial metabolites isolated from Hyphomycetes (178–189).
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FIGURE 14 | Structures of antibacterial metabolites isolated from Hyphomycetes (190–204).
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Rhein (195) (Figure 14) was isolated from an endophyte
Fusarium solani of Rheum palmatum collected at Ruoergai
County, Sichuan Province, China. Rhein (195) naturally occurs in
anthraquinone (1, 3, 8-trihydroxy-6-Me anthraquinone), that is
found in Rheum palmatum L. and related plants such as rhubarb
(You et al., 2013). It has good antibacterial activity with MICs
in the range of 0.6–4μg/mL against S. aureus, S. aureus nor A,
B. megaterium 11561, Pseudomonas syringae and Sinorhizobium
meliloti (Tegos et al., 2002).
Sanguinarine (196) (Figure 14), a benzophenanthridine alka-
loid was obtained from the endophyte Fusarium proliferatum
(strain BLH51) present on the leaves of Macleaya cordata of the
Dabie Mountain, China. It has antibacterial, anthelmintic, and
anti-inflammatory activities (Wang et al., 2014). It has antibac-
terial activities against the range of bacteria with MICs of 3.12–
6.25μg/mL against 15 clinical isolates of S. aureus while the MICs
against of the two reference strains are 3.12μg/mL for ATCC
25923 and 1.56μg/mL for ATCC 33591.
The clinical isolates strains showed MIC values ranging
from 31.25 to 250μg/mL for ampicillin and 125–1000μg/mL
for ciprofloxacin. The treatment of the cells with sanguinar-
ine induced the release of membrane-bound cell wall autolytic
enzymes, which eventually resulted in lysis of the cell.
Transmission electron microscopy (TEM) of MRSA treated with
Sanguinarine show alterations in septa formation. The predis-
position of lysis and altered morphology seen by TEM indicates
that sanguinarine acts on the cytoplasmic membrane (Obiang-
Obounou et al., 2011). The compound also has activity against
plaque bacteria with MICs of 1–32μg/mL for most species tested.
The Electron microscopic studies of bacteria exposed to san-
guinarine show that they aggregate and become morphologically
irregular (Godowski, 1989).
Shikimic acid (197) (Figure 14), was obtained from the endo-
phyte Trichoderma ovalisporum strain PRE-5 of the root of the
herbal Panax notoginseng. The compound (197) is activity against
S. aureus, Bacillus cereus, M. luteus and E. coli (Dang et al., 2010).
Trichoderic acid (198), 2β-Hydroxytrichoacorenol (199),
Cyclonerodiol (200), Cyclonerodiol oxide (201), and Sorbicillin
(202) (Figure 14), were isolated from a Trichoderma sp. PR-35,
an endophyte of Paeonia delavayi. These compounds are active
against E. coli and S. albus with minimal inhibitory amount
(MIA) values in the range of 25–150mg/disk. Compounds (198),
(200) and (201) are active against Shigella sonnei with MIA values
in the range of 100–150μg/disk (Wu et al., 2011).
Cyclopeptides PF1022F (203) and Halobacillin (204)
(Figure 14), were isolated from the endophyte Trichoderma
asperellum from traditional Chinese medicinal plant Panax noto-
ginseng. Compounds (203) and (204) are active against E. faecium
(CGMCC 1.2025) with IC50 values of 7.30 and 5.24μM and
against S. aureus COL (CGMCC 1.2465) with IC50 values of
19.02 and 14.00μM, respectively (Ding et al., 2012).
Tetrahydrobostrycin (205), 4-Deoxytetrahydrobostrycin
(206), 3,6,8-Trihydroxy-1- methylxanthone (207),
Griseophenone C (208) and 2,3-Didehydro-19α-hydroxy-
14-epicochlioquinone B (209) (Figure 15), were isolated from
the endophyte Nigrospora sp. MA75, of the mangrove plant
Pongamia pinnata collected from Guangxi Zhuang Autonomous
Region of China. Compound (209) has excellent activity against
all the tested bacteria (MRSA, E. coli, P. aeruginosa, P. fluo-
rescens and S. epidermidis) with MIC values of 8, 4, 4, 0.5, and
0.5μg/mL, respectively. The activity toward E. coli, P. fluorescens
and S. epidermidis was stronger than that of the positive control
(Ampicillin, with MICs values of 8, 4, and 4μg/mL, respectively).
Compound (208) strongly inhibits MRSA, E. coli, P. aeruginosa,
and P. fluorescens at MIC values of 0.5, 2, 0.5, and 0.5μg/mL,
respectively. Compound (205) has significant activity toward
MRSA and E. coli (MIC 2 and 0.5μg/mL, respectively), while
its analog compound (206), is only activity against E. coli (MIC
4μg/mL). This indicates that the OH group at C (4) could be
important for the activity against MRSA. Compound (207) is
active only against S. epidermidis (MIC 0.5μg/mL) (Shang et al.,
2012).
4-Deoxybostrycin (210) and its derivative Nigrosporin (211)
(Figure 15), were isolated from the mangrove endophyte
Nigrospora sp. of the South China Sea. These compounds are
active against M. tuberculosis and clinical multidrug-resistant
(MDR) M. tuberculosis strains with MIC values of <5–>
60μg/mL (Wang et al., 2013b).
Periconicins A (212) and B (213) (Figure 15), were isolated
from an endophyte Periconia sp., from the branches of Taxus
cuspidata. Periconicin A (212) has significant activity against
B. subtilis, S. aureus, K. pneumoniae, and Salmonella typhimurium
with MICs in the range of 3.12–12.5μg/mL. Periconicin B (213)
has modest antibacterial activity against the same strains with
MICs in the range 25–50μg/mL (Kim et al., 2004).
Piperine (214) (Figure 15), which was originally isolated from
Piper longum, was also detected from the endophyte Periconia sp.
of the same plant. Piperine has strong activity against M. tuber-
culosis and M. smegmetis with MICs of 1.74 and 2.62μg/mL
respectively (Verma et al., 2011).
Modiolide A, 5, 8-dihydroxy-10-methyl-5, 8, 9, 10-
tetrahydro-2H-Oxecin-2-one (215) and 4-Chromanone,
6-hydroxy-2-methyl- (5CI) (216) (Figure 15) were isolated from
the endophyte Periconia siamensis (strain CMUGE015) of the
leaves of the grass, Thysanoleana latifolia (Poaceae). Compound
(215) is active against Bacillus cereus, Listeria monocytogenes,
MRSA, P. aeroginosa and E. coli with MIC of 3.12, 6.25, 25.00,
12.50, and 50.00μg/mL respectively. Compound (216) is active
against B. cereus, Listeria monocytogenes, MRSA, P. aeruginosa
and E. coli with MICs of 6.25, 12.50, 50.00 25.00, 12.50, and
100.00μg/mL respectively (Bhilabutra et al., 2007).
Xanalteric acids I (217) and II (218) (Figure 15) and Altenusin
(219) (Figure 16), were obtained from Alternaria sp., of the man-
grove plant Sonneratia alba. These (217–218) has weak antibacte-
rial activities against MRSA with MICs of 125 and 250μg/mL.
Altenusin (219) exhibited broad antimicrobial activity against
several resistant pathogens (MRSA, S. pneumonia, E. faecium,
E. cloacae and A. faecalis) with MIC values of 31.25–125μg/mL
(Kjer et al., 2009).
1-(2, 6-dihydroxyphenyl) butan-1-one (220) (Figure 16), was
isolated from the endophyteNodulisporium sp. of Juniperus cedrus
from Gomera Island. Compound (220) is active against B. mega-
terium at 0.25mg/filter disc with 15mm zone of inhibition (Dai
et al., 2006).
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FIGURE 15 | Structures of antibacterial metabolites isolated from Hyphomycetes (205–218).
Nodulisporins D-F (221–223), Benzene- 1, 2, 3-triol (224)
(Figure 16), were isolated from an endophyte Nodulisporium sp.
of Erica arborea. Compounds (221–224) showed activity against
B. megaterium (Dai et al., 2009b).
Pyrrocidine (113) (Figure 9), was isolated from Acremonium
zeae an endophyte of maize. Compound (113) has potent activ-
ity against Clavibacter michiganense subsp. Nebraskense a causal
agent of Goss’s bacterial wilt of maize (MICs 1–2μg/mL), as well
as Bacillus mojavensis (MICs 1–2μg/mL) and P. fluorescens (MICs
1–2μg/mL) (Wicklow and Poling, 2009).
Rhizoctonic acid (139), Monomethylsulochrin (138)
(Figure 9), Ergosterol (79) (Figure 5) and 3β, 5α, 6β-
trihydroxyergosta-7, 22-diene (225) (Figure 16), were isolated
from a Rhizoctonia sp. (Cy064), the endophyte in the leaves of
Cynodon dactylon. Compounds (139, 138, 79, and 225) are active
against five clinical and one reference strain of H. pylori (ATCC
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FIGURE 16 | Structures of antibacterial metabolites isolated from Hyphomycetes (219–232).
Frontiers in Microbiology | Microbial Physiology and Metabolism January 2015 | Volume 5 | Article 715 | 34
Deshmukh et al. Antibacterials from endophytic fungi
43504) with MICs in the range 10.0–30.0μg/mL (Ma et al.,
2004).
Ophiobolins P (226) and T (227) (Figure 16), were isolated
from the endolichenic fungus Ulocladium sp. Ophiobolins P has
moderate antibacterial activity against B. subtilis and MRSA with
MICs of 62.5 and 31.3μg/mL respectively. Ophiobolin T (227)
has moderate activity against B. subtilis and MRSA and Bacille
Calmette-Guerin strain with MICs of 31.3 15.6 and 31.3μg/mL
respectively (Wang et al., 2013a).
The antibacterial naphthaquinone Javanicin (181) (Figure 13)
was isolated from an endophyte Chloridium sp. of Azadirachta
indica. This compound is very active against P. fluorescens and
P. aeruginosa with MIC of 2μg/mL (Khrawar et al., 2009).
(3S)-Lasiodiplodin (228), (R)-(−)-Mellein (229), Cis-(3R,
4R)-(−)-4-Hydroxymellein (230), trans-(3R, 4S)-(−)-4-
Hydroxymellein (231), (R)-(−)-5-Hydroxymellein (232)
(Figure 16) were isolated from the endophyte Botryosphaeria
rhodina PSU-M35 and PSU-M114. Compound (228) is very
active against S. aureus and MRSA with MIC values of 64
and 128μg/mL respectively. Compounds (229–232) have
much weaker activities than compound (228) with MIC
values >128μg/mL (Rukachaisirikul et al., 2009).
Fusidilactones D (233) and E (234) (Figure 17) were isolated
from the endophyte, a Fusidium sp. from the leaves of Mentha
arvensis growing in a meadow near Hahausen, Lower Saxony,
Germany. Both compounds are weakly active against E. coli and
B. megaterium (Qin et al., 2009).
Palmariol B (235), 4-Hydroxymellein (236), Alternariol 9-
methyl ether (237) and Botrallin (238) (Figure 17) were isolated
from an endophyte, Hyalodendriella sp. Ponipodef 12, of the
hybrid “Neva” of Populus deltoides Marsh × P. nigra L. MIC50
values of the compounds on Agrobacterium tumefaciens ranged
from 18.22 to 87.52μg/mL. Against B. subtilis, P. lachrymans,
R. solanacearum and X. vesicatoria, MICs50 were from 19.22 to
98.47, 16.18 to 92.21, 16.24 to 85.46 and 17.81 to 86.32μg/mL
respectively (Meng et al., 2012).
Alterporriol N (239), Alterporriol D (240), and Alterporriol
E (241) (Figure 17), were isolated from Stemphylium globu-
liferuman an endophyte of Mentha pulegium collected from
Morocco. Alterporriol N (239) is active against MRSA and
E. faecalis with MICs of 62.5 and 15.63μg/mL. Alterporriol D
(240) is active against MRSA and Streptomyces pneumonia with
an MIC of 31.25μg/mL. Alterporriol E (241) is active against
S. pneumonia, E. faecalis and Enterobacter cloacae with MICs of
31.25μg/mL each (Debbab et al., 2009).
COMPOUNDS PRODUCED FROM UNIDENTIFIED FUNGI
Nonsporulating fungi form a major group of such endo-
phytes. Khafrefungin, Arundifungin are antifungals reported
from such fungi (Deshmukh and Verekar, 2012). Bostrycin (242)
(Figure 18) isolated from the mangrove endophyte, no. 1403, of
the South China Sea (Xu et al., 2010a), shows antibacterial activity
against B. subtilis (Charudattan and Rao, 1982).
Guanacastepene A (243) (Figure 18), a novel diterpenoid
produced the fungus CR115 isolated from the branch of
Daphnopsis americana growing in Guanacaste, Costa Rica, may
prove to belong to potentially new class of antibacterial agents
with activities against MRSA and VRE (Singh et al., 2000).
Guanacastepene I (244) (Figure 18), was isolated from the same
fungus is active against S. aureus (Brady et al., 2001).
Anhydrofusarubin (245) (Figure 18), was isolated from the
endophyte no. B77 of a mangrove tree on the South China Sea
coast. Compound (245) is active against Staphylococcus aureus
(ATCC27154) with a MIC of 12.5μg/mL (Shao et al., 2008b).
3-O-Methylfusarubin (182) (Figure 13), Fusarubin (246)
(Figure 18), were isolated from the endophyte B77 present in
the seeds of the mangrove plant Kandelia candel in Zhanjiang.
Compounds (182) and (246) were active against S. aureus ATCC
27154 with MIC values of 50.0 and 12.5μg/mL, respectively
(Shao et al., 2008a).
Compound (247), 9α –Hydroxyhalorosellinia A (248) and
Desoxybostrycin (249) (Figure 18), were isolated from the endo-
phyte PSU-N24 present in the plant Garcinia nigrolineata col-
lected from the Ton Nga Chang wildlife sanctuary, Songkhla
province, southern Thailand. Compound (248)was active against
M. tuberculosis with the MIC value of 12.50μg/mL whilst com-
pounds (247) and (249) had MIC values of 25 and 50μg/mL,
respectively (Sommart et al., 2008).
Indolyl-3-carboxylic acid (250) (Figure 18), isolated from the
endophyte S20 of Cephalotaxus hainanensis Li. showed inhibi-
tion of S. aureus and MRSA with diameters of inhibition zones
of which were 12 and 8mm, respectively when 50μl of the
compound (10 mg/mL) impregnated on sterile filter paper discs
(6-mm diameter) (Dai et al., 2009a). The structure of a new 5-
acyl-2-methylpyrrole (251) (Figure 18) from the same endophyte
S20 of Cephalotaxus hainanensis, was shown to be 1-(5-methyl-
1H-pyrrol-2-yl)-2-((2S*, 3R*)-3-((E)-prop-1-enyl) oxiran-2-yl)
ethanone. Compound (251) is active against S. aureus andMRSA.
The diameters of inhibition are 12.0mm and 10.0mm respec-
tively when 50μL (10mg/mL) of the compound was impregnated
on sterile filter paper discs (6-mm diameter) (Dai et al., 2009c).
Spirobisnaphthalenes, namely Diepoxin κ (252), Diepoxin η
(253), and Diepoxin ζ (254) (Figure 18), were isolated from the
endophyte Dzf12 of the medicinal plant Dioscorea zingiberensis.
Among these, compound (252) has antibacterial activity, against
E. coli, A. tumefaciens, X. vesicatoria, P. lachrymans and B. sub-
tilis with MICs from 50 to 100μg/mL. A mixture of diepoxin η
(253), and diepoxin ζ (254) showed antibacterial activity against
the same set of bacteria with aMICs range of 5.0–12.5μg/mL (Cai
et al., 2009).
4-Hydroxyphthalide (255), 5-methoxy-7-hydroxyphthalide
(256), (3R, 4R)-cis-4 hydroxymellein (257) (Figure 19), were
obtained from an unidentified Ascomycete from Meliotus denta-
tus of the coastal area of the Baltic Sea, Ahrenshoop, Germany.
Compounds (255) and (256) were active against E. coli whereas
(256) and (257) were active against B. megaterium (Hussain et al.,
2009b).
Pestalotheols E-H (258–261) and Anofinic acid (262)
(Figure 19), were obtained from an unidentified ascomycete of
Arbutus unedo. Compounds (258–262) have antibacterial activity
against E. coli and B. megaterium (Qin et al., 2011).
Guignardone I (263) and Guignardone B (264) (Figure 19),
were isolated from an endophyte fungus A1 of themangrove plant
Scyphiphora hydrophyllacea. Guignardone I (263) shows zones
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FIGURE 17 | Structures of antibacterial metabolites isolated from Hyphomycetes (233–241).
inhibition of 9.0 and 11.0mm in diameter, using 6mm filter
paper discs toward MRSA and S. aureus at 65μM, respectively.
Guignardone B (264) shows zones of 8.0mm against MRSA at
65μM. Kanamycin sulfate, used as positive control (10μL of
0.08mg/mL) showed an inhibition zone of 30mm (Mei et al.,
2012).
Mirandamycin (265) (Figure 19) was obtained from isolate
1223-D, an unclassified fungus of twig of Neomirandea angu-
laris of family Asteraceae. It is active against E.coli 25922,
P. aeruginosa 27853,K. pneumoniae carbapenemase positive BAA-
1705, MRSA BAA-976 and V. cholerae PW357 with MICs of
80, 80, >80, 10, and 40μg/mL respectively (Ymele-Leki et al.,
2012).
Volatile organic compounds from endophytic fungi
Strobel et al. (2001) reported at least 28 volatile organic com-
pounds (VOC) from the xylariaceaous endophyte Muscodor
albus (isolate 620), of Cinnamomum zeylanicum from Lancetilla
Botanical Garden near La Ceiba, Honduras. These VOC’s aremix-
tures of gasses of five class’s viz. alcohols, acids, esters, ketones
and lipids. The most effective were the esters, of which, 1-
butanol, 3-methyl-acetate has the highest activity. The VOC’s
inhibited and killed certain bacteria, within a period of 1–3
days. Most test organisms were completely inhibited, and in
fact killed. These includes Escherichia coli, Staphylococcus aureus,
Micrococcus luteus and Bacillus subtilis along with some fungal
species.
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FIGURE 18 | Structures of antibacterial metabolites isolated from Unidentified fungus (242–256).
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FIGURE 19 | Structures of antibacterial metabolites isolated from Unidentified fungus (257–265).
Strain of Muscodor namely Muscodor crispans of Ananas
ananassoides (wild pineapple) growing in the Bolivian Amazon
Basin produces VOC’s; namely propanoic acid, 2-methyl-; 1-
butanol, 3-methyl-; 1-butanol, 3-methyl-, acetate; propanoic
acid, 2-methyl-, 2-methylbutyl ester; and ethanol. The VOC’s of
this fungus are effective against Xanthomonas axonopodis pv. citri
a citrus pathogens. The VOC’s of M. crispans kill several human
pathogens, including Yersinia pestis, Mycobacterium tuberculosis
and Staphylococcus aureus. Muscodor crispans is only effective
against the vegetative cells of Bacillus anthracis, but not against
the spores. Artificial mixtures of the fungal VOC’s were both
inhibitory and lethal to a number of human and plant pathogens,
including three drug-resistant strains of Mycobacterium tubercu-
losis (Mitchell et al., 2010). Themechanism of action of the VOC’s
of Muscodor spp. on target bacteria is unknown. A microarray
study of the transcriptional response analysis of B. subtilis cells
exposed to M. albus VOC’s show that the expression of genes
involved in DNA repair and replication increased, suggesting
that VOC’s induce some type of DNA damage in cells, possibly
through the effect of one of the naphthalene derivatives (Mitchell
et al., 2010).
Outlook
A definite, urgent and worldwide effort is needed to tackle the
problems of the populations in third world and developing coun-
tries. MRSA, VRE, PRSP, ESCAPE organisms have spread through
these countries over the years particularly due to immunocom-
promised populations. Mycobacterium tuberculosis is a major
threat! and New and Novel drugs are a must!! Endophytic fungi
may be an excellent source of such compounds. These organisms
have a vast repertoire of diverse chemicals such as steroids, xan-
thones, phenols, isocoumarins, perylene derivatives, quinones,
furandiones, terpenoids, depsipeptides and cytochalasins (Tan
and Zou, 2001; Gunatilaka, 2006; Zhang et al., 2006; Guo et al.,
2008).
A major challenge in Drug Discovery Program based on endo-
phytic fungi lies in developing effective strategies to isolating
bioactive strains. Strobel and Daisy (2003) suggested that areas
of high biodiversity of endemic plant species may hold the great-
est potential for endophytes with novel chemical entities. Tropical
forests are some of the most bio diverse ecosystems and their
leaves are “biodiversity hotspots” (Arnold and Lutzoni, 2007).
The selection of plants is crucial. Those with medicinal properties
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should be given preference. Metabolites produced by fungi need
to correlated with the plant genomics, thus allowing far better
knowledge of biosynthetic pathways. This will also justify the
production of metabolites rather than unproven hypotheses.
Identification of endophytic fungi using molecular analyses
provides an opportunity to look for broad patterns in bioactivity
not only at the genotype or strain level, but at higher taxonomic
levels that may in turn assist in focusing on the association of
metabolite with the plant.
The endophytic flora of the Indian subcontinent has been
explored for their diversity but not enough for their bioactive
metabolites. The published work is scanty (Puri et al., 2005;
Deshmukh et al., 2009; Khrawar et al., 2009; Periyasamy et al.,
2014). There is a need for groups from different scientific disci-
pline (mycologist, chemist, toxicologist, and pharmacologist) to
engage in this search process. Enormous natural wealth exists in
the world’s tropical forests, but disparity exists between devel-
oped countries with their financial resources and biodiversity rich
countries with underdeveloped economy and limited funds. May
be funding agencies need to look at such aspects.
The need of a more and larger collection of fungal endopytes is
suggested. Bioactive metabolite metabolites from such collections
could yield leads for pharmaceutical and agricultural application.
What emerges is the essential bonding of various discipline of
biology and chemistry into cohesive target delivery vehicles.
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